UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000061256
Receipt number R000070096
Scientific Title Association between stigma and treatment satisfaction in patients with type 2 diabetes: A cross-sectional study
Date of disclosure of the study information 2026/04/15
Last modified on 2026/04/14 14:41:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Association between stigma and treatment satisfaction in patients with type 2 diabetes: A cross-sectional study

Acronym

Association between stigma and treatment satisfaction in patients with type 2 diabetes

Scientific Title

Association between stigma and treatment satisfaction in patients with type 2 diabetes: A cross-sectional study

Scientific Title:Acronym

Association between stigma and treatment satisfaction in patients with type 2 diabetes

Region

Japan


Condition

Condition

type 2 diabetes

Classification by specialty

Medicine in general Endocrinology and Metabolism Psychosomatic Internal Medicine
Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the association between stigma and treatment satisfaction in patients with type 2 diabetes.

Basic objectives2

Others

Basic objectives -Others

To investigate the association between stigma and clinical parameters in patients with type 2 diabetes.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Association between stigma and treatment satisfaction in patients with type 2 diabetes

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with type 2 diabetes who visited our outpatient clinic

Key exclusion criteria

Patients with missing responses to the questionnaire survey

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Ito

Organization

Edogawa Hospital

Division name

Department of Diabetes, Metabolism and Kidney Disease

Zip code

1300022

Address

2-24-18, Higashikoiwa, Edogawa-ku, Tokyo

TEL

03-3673-1221

Email

ito@edogawa.or.jp


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Ito

Organization

Edogawa Hospital

Division name

Department of Diabetes, Metabolism and Kidney Disease

Zip code

1300022

Address

2-24-18, Higashikoiwa, Edogawa-ku, Tokyo

TEL

03-3673-1221

Homepage URL


Email

ito@edogawa.or.jp


Sponsor or person

Institute

Edogawa Hospital

Institute

Department

Personal name



Funding Source

Organization

Edogawa Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Edogawa Hospital

Address

2-24-18, Higashikoiwa, Edogawa-ku, Tokyo

Tel

03-3673-1221

Email

ito@edogawa.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

300

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2025 Year 09 Month 10 Day

Date of IRB

2025 Year 09 Month 10 Day

Anticipated trial start date

2025 Year 09 Month 11 Day

Last follow-up date

2026 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Cross-sectional study


Management information

Registered date

2026 Year 04 Month 14 Day

Last modified on

2026 Year 04 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070096